Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 35Breast 27Thoracic 23Gynecologic 18Head & Neck 11Tumor-Agnostic 5Genitourinary 5Dermatologic 5Sarcoma 4Other neoplasm 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Gastric Adenocarcinoma 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Melphalan 3fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Taxes 2Tacrolimus 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Mycophenolic Acid 2Magnetic Resonance Spectroscopy 2Educational Status 2Cyclophosphamide 2Busulfan 2Aminolevulinic Acid 2venetoclax 1tirbanibulin 1taxane 1ruxolitinib 1radium Ra 223 dichloride 1X-Rays 1Sirolimus 1Robotic Surgical Procedures 1Resistance Training 1Platinum 1Photons 1Patient Reported Outcome Measures 1Methotrexate 1Methods 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Taxes × Other neoplasm × 90 days × Clear all
NCT04090398 2026-05-13

Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones

National Cancer Institute (NCI)

Phase 2 Active not recruiting
70 enrolled
BreastOther neoplasm

Anatomic Stage IV Breast Cancer AJCC v8

NCT05753306 2026-04-08

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Mayo Clinic

Phase 2 Recruiting
40 enrolled
GastrointestinalOther neoplasm

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡